Colchicine
Links shared publicly online about this topic
Colchicine for Recurrent Pericarditis (CORP)
annals.org — “Colchicine for Recurrent Pericarditis (CORP)” View full resource at annals.org
Most Recently Shared on August 29, 2011 at 5:37 am By:
M Auron MD Doctor, Pediatrician, Internist, and Physician
Colchicine - effective to prevent recurrent pericarditis - http://t.co/fuN2hsW
Colchicine for Recurrent Pericarditis (CORP)
annals.org — “Colchicine for Recurrent Pericarditis (CORP)” View full resource at annals.org
Most Recently Shared on August 29, 2011 at 1:43 pm By:
ACP Hospitalist Medical Journal
RT @AnnalsofIM: Early release: Colchicine proven safe and effective for recurrent pericarditis. http://t.co/obzIlf5
Rheumatology Article | Colchicine
mdlinx.com — “Colchicine in clinical medicine. A guide for internists” View full resource at mdlinx.com
Most Recently Shared on December 8, 2010 at 10:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Colchicine in clinical medicine. A guide for internists: European Journal of Internal Medicine http://bit.ly/fmWLjE #Rheumatology
FDA Alert: Colchicine (marketed as Colcrys)
drugs.com — “FDA Alert: Colchicine (marketed as Colcrys)” View full resource at drugs.com
Most Recently Shared on July 31, 2009 at 3:10 am By:
FDA Alert - New Safety Information for Colchicine (marketed as Colcrys) - http://bit.ly/IrGMI
FDA Approves Colchicine for Acute Gout, Mediterranean Fever
fda.gov — “The U.S. Food and Drug Administration has approved Colcrys to treat acute flairs in patients with gout, a recurrent and painful form of arthritis, and patients with familial Mediterranean fever (FMF), an inherited inflammatory disorder. The medication's active ingredient is colchicine, a complex compound derived from the dried seeds of a plant known as the autumn crocus or meadow saffron (Colchicum autumnale).” View full resource at fda.gov
Most Recently Shared on July 31, 2009 at 3:49 pm By:
eyeonfda Pharma and Health Lawyer
FDA Approves Colchicine for Acute Gout, Mediterranean Fever http://bit.ly/v4fZ4
FDA to ban unapproved oral colchicine products | Reuters
reuters.com — “LONDON (Reuters) - U.S. regulator the Food and Drug Administration (FDA) intends to ban unapproved oral colchicine products to treat gout, according to a document posted online by the U.S. Office of the” View full resource at reuters.com
Most Recently Shared on October 1, 2010 at 9:00 am By:
Hisham Rana, MD Doctor and Physician
News: FDA to ban unapproved oral colchicine products http://reut.rs/bilp2e - #health
Single-Ingredient Oral Colchicine Video
fda.gov — “Single-Ingredient Oral Colchicine Video” View full resource at fda.gov
Most Recently Shared on May 21, 2010 at 7:01 pm By:
Men's Health Network Health Organization
FDA debuts new educational video series on drug safety: http://ht.ly/22Fry
Colchicine in the Treatment of Acute Low Back Pain
spineuniverse.com — “Colchicine has been regarded by some as the most powerful anti-inflammatory agent known to man. Learn how this medication is used to treat acute low back pain.” View full resource at spineuniverse.com
Most Recently Shared on February 19, 2011 at 8:17 pm By:
Colchicine in the Treatment of Acute Low Back Pain http://dlvr.it/H2HRv
Ob/Gyn Medical News about Colchicine
mdlinx.com — “Pregnancy outcome after in utero exposure to colchicine” View full resource at mdlinx.com
Most Recently Shared on July 9, 2010 at 5:08 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Pregnancy outcome after in utero exposure to colchicine: American Journal of Obstetrics and Gynecology http://bit.ly/bFTWhJ #OBG
Colchicine proves 'safe and effective' in the prevention of recurrent pericarditis
medicalxpress.com — “Colchicine, when given in addition to conventional therapy, was more effective than placebo in reducing the incidence of recurrence and the persistence of symptoms of pericarditis in a randomised controlled trial. This is the first time that the efficacy of colchicine in preventing recurrent episodes ...” View full resource at medicalxpress.com
Most Recently Shared on August 29, 2011 at 3:51 pm By:
PhysOrg Health News Health News
Colchicine proves 'safe and effective' in the prevention of recurrent pericarditis http://t.co/BHjdGql
Colchicine more effective than placebo for recurrent pericarditis
news-medical.net — “Colchicine, when given in addition to conventional therapy, was more effective than placebo in reducing the incidence of recurrence and the persistence of symptoms of pericarditis in a randomised controlled trial.” View full resource at news-medical.net
Most Recently Shared on August 29, 2011 at 6:12 am By:
Colchicine more effective than placebo for recurrent pericarditis: Colchicine, when given in addition to convent... http://t.co/cG1VHu9
FDA halts marketing of unapproved colchicine - ONA
oncologynurseadvisor.com — “The FDA has informed companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine that they are expected to stop manufacturing single-ingredient oral colchicine within 45 days and must stop shipping this unapproved product in interstate commerce within 90 days.” View full resource at oncologynurseadvisor.com
Most Recently Shared on October 1, 2010 at 3:04 pm By:
OncologyNurseAdvisor Oncology, Nursing, Medical Education, and Medical Publisher
FDA halts marketing of unapproved colchicine http://goo.gl/fb/qkw7J
FDA halts marketing of unapproved colchicine - MPR
empr.com — “The FDA has informed companies that manufacture, distribute, and/or market unapproved single-ingredient oral colchicine that they are expected to stop manufacturing single-ingredient oral colchicine within 45 days and must stop shipping this unapproved product in interstate commerce within 90 days.” View full resource at empr.com
Most Recently Shared on October 1, 2010 at 3:20 pm By:
MPR News: FDA halts marketing of unapproved colchicine: The FDA has informed companies that manufacture, distribut... http://bit.ly/bPH8tn
Spotlight on Colchicine: The Colcrys Controversy - General Medicine
t.co — “On April 16, 2010, we summarized an article on an industry-sponsored randomized trial of colchicine for acute gout flares (JW Gen Med Apr 16 2010). But why did a drug company choose to . . .” View full resource at t.co
Most Recently Shared on April 21, 2011 at 9:24 pm By:
David Rubin Internist, Physician, and Doctor
78% of US Rxs are for generics (http://t.co/6QhFkId). Bad trend: "Brand"ing generics via FDA UDI (ProAir HFA, Colcrys) http://t.co/L0fNbQe.
FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares
drugs.com — “Colcrys (colchicine) is used for prevention of gout. Includes Colcrys side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on October 26, 2009 at 11:03 pm By:
FDA Approves Colcrys (colchicine, USP) for Prevention of Gout Flares - http://bit.ly/z5QWo
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Featuring the top 3 experts for this topic
-
M Auron MD
Internist and Pediatrician. Hospitalist.
-
ACP Hospitalist
ACP Hospitalist provides news and information for hospitalists, covering the latest trends and issues in the field.
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
